Asserter profile
Aegis Therapeutics, LLC and Neurelis, Inc.
operating company3 patents now4 ever0 cases filed during tenure1 connection
Also seen as: AEGIS THERAPEUTICS, LLC and NEURELIS, INC.
PTAB exposure
2of this entity’s patents have been challenged at PTAB (2 total proceedings).
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
Naegis_therapeutics_and_neurelis["Aegis Therapeutics, LLC and Neurelis, I…"]
Norbimed_royalty_and_credit_opportunities_iii["OrbiMed Royalty & Credit Opportunities…"]
Nneurelis_and_aegis_therapeutics["Neurelis, Inc. and Aegis Therapeutics,…"]
Naegis_therapeutics_and_neurelis -->|"2021 · Security Agreement · 11793786"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 11793786"| Naegis_therapeutics_and_neurelis
Naegis_therapeutics_and_neurelis -->|"2023 · Security Agreement · 12599611"| Norbimed_royalty_and_credit_opportunities_iii
Naegis_therapeutics_and_neurelis -->|"2022 · Security Agreement · 12337061"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 12337061"| Naegis_therapeutics_and_neurelis
Naegis_therapeutics_and_neurelis -->|"2021 · Security Interest · 12324852"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 12324852"| Naegis_therapeutics_and_neurelis
Naegis_therapeutics_and_neurelis -->|"2021 · Security Agreement · 11241414"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 11241414"| Naegis_therapeutics_and_neurelis
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 12599611"| Nneurelis_and_aegis_therapeutics
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class Naegis_therapeutics_and_neurelis focal
class Nneurelis_and_aegis_therapeutics operating
Patents currently held (4)
- US 123370612024-11-14 → present
- US 123248522024-11-14 → present
Connected entities (1)
- OrbiMed Royalty & Credit Opportunities III, LPunclassified5 patents